The course was established 22 November 2006.
This course syllabus (version 1) was approved 15 March 2012 by the Faculty Board of Health and Society .
The syllabus is valid from 03 September 2012.
The course aims to enable the students to identify artificial and biological interfaces in biomedical methods and technology.
Advancement in relation to the degree requirements
The course is mandatory and is given in the first semester of the Master Programme Biomedical Methods and Technology. The course can also be taken as a freestanding course.
1. Bachelor’s degree (180 hp) or equivalent with a major in chemistry, biochemistry, biomedical technology, biomedical methods and technology, biomedical laboratory science or in other areas of natural, medical, engineering sciences or technology with a minimum of 15 hp in chemistry and/or biochemistry.
2.The equivalent of English B in Swedish secondary school.
After completing the course the student should be able to
- define and explain the terms artificial and biological interfaces,
- discuss phenomena at artificial and biological interfaces, and
- explain how the processes at artificial and biological interfaces are involved or used in the products or activities of biomedical and biotech industry.
To pass the following is required: approved reports and passed examination.
The course content is graded as follows:
A - Excellent
B - Very Good
C - Good
D - Satisfactory
E - Pass
U - Fail
Students who fail the examination are entitled to at least two retakes with the same course contents and the same requirements to pass. If the course is discontinued or revised, students retain the right to two retakes within one year, based on the original content. The examination and retakes are conducted only at specifically appointed occasions.
The main area of biomedical methods and technology is defined. The role of artificial and biological interfaces in research and development of biomedical and biotech industry is emphasised. The main molecular, surface chemical and biological phenomena at artificial and biological interfaces are discussed with focus on their applications in biomedical methods and products of biomedical technology. The performance, development and growth of biomedical and biotech industry at the Malmö-Copenhagen region are analysed and summarised.
Lectures, seminars, and independent studies. Web-based reporting, communication and distribution of education materials are used.
Excellent (A), Very Good (B), Good (C), Satisfactory (D), Pass (E) or Fail (U).
Reading list and other media
Shreefal S. Mehta. Commercializing successful biomedical technologies. Basic principals for the development of drugs, diagnostics and devices
. Cambridge University Press, Cambridge, 2008, pp. 335.
Medicon Valley Alliance. Directory 2008: Academia, Businesses and Public Organisations in Medicon Valley. Birch & co. a/s, Copenhagen, 2008, pp. 84.
To cover the contents of the course scientific papers will be distributed.
A comprehensive course evaluation is carried out at the end of the course. The students are asked to evaluate the quality of the course based on the learning outcomes and how these have been realised. The course coordinator discusses the evaluation results with the students at a pre-announced occasion. The evaluation is subsequently summarised and published on the course website. The evaluation is also discussed the next time the course is given.
The course will be given in English, but in case of absence of foreign students lectures might be given in Swedish.